Zydus gets USFDA approval for Indomethacin suppository with CGT designation EP News Bureau Aug 3, 2023 The company has been granted 180-day CGT exclusivity to market this product
Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab EP News Bureau Mar 1, 2023 This is the company’s fourth biosimilar launch in recent times
AYUSH Ministry to conduct clinical trial in Ayurveda for rheumatoid arthritis Press Information Bureau Mar 24, 2022 This project is one of the first multi-centre phase-III double-blind double-dummy clinical trials on the efficacy of Ayurveda in…
Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib) EP News Bureau Dec 16, 2020 Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis EP News Bureau Sep 25, 2020 Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
Lupin launches Leflunomide Tablets USP EP News Bureau Sep 2, 2020 These tablets are indicated for the treatment of adults with active rheumatoid arthritis
Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India EP News Bureau Aug 29, 2020 It is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis
Dr Reddy’s Laboratories launches penicillamine capsules in US EP News Bureau Aug 27, 2020 It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat…
Lupin and Mylan launch Nepexto, biosimilar etanercept in German market EP News Bureau Aug 26, 2020 Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective…
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib EP News Bureau Aug 20, 2020 The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…